Danielle Lauzon > Goodwin > Boston, United States > Lawyer Profile
Goodwin Offices
100 NORTHERN AVENUE
BOSTON MA 02210
MASSACHUSETTS
United States
- Firm Profile
- Go to...
Danielle Lauzon
Position
Partner / Boston Business Leader
Career
Danielle Lauzon is a partner in Goodwin’s Technology and Life Sciences groups, and leader of the firm’s Business Law Department in Boston. Ms. Lauzon represents issuers in connection with the public offering and private placement of equity securities, and has represented companies as well as venture capital and private equity firms in numerous venture capital financings and recapitalizations.
Ms. Lauzon acts as co-chair of Goodwin’s PropSci practice which is focused on supporting the intersection of real estate and life sciences. Through our industry and practice area connectivity, and leveraging our existing reputation as leaders in the real estate and life sciences spaces, Goodwin provides clients integrated and innovative services that adapt along with their needs.
Ms. Lauzon currently serves on Goodwin’s Partnership Committee.
Education
JD, Villanova University School of Law (magna cum laude) 2000 / BA, University of Michigan 1997
Lawyer Rankings
United States > M&A/corporate and commercial > Venture capital and emerging companies
(Next Generation Partners)Goodwin has a top tier venture capital practice, noted for its ‘very professional, knowledgeable and responsive’ teams of lawyers who are ‘real partners in growing the business‘. The ‘very business oriented, extremely practical‘ group offers ‘expert legal advice‘ to investors and startups, and stands out for its market-leading life sciences group, primarily based in the firm’s Boston office and co-chaired by Mitchell Bloom and Kingsley Taft. The firm’s ability to guide clients from early financing rounds through to later stage M&A, can be seen through its advice to Navitor Pharmaceuticals on the sale of Anakuria Therapeutics to Janssen Pharmaceuticals – a deal led by Danielle Lauzon, co-chair of the firm’s PropSci practice. The firm’s technology group, jointly led by Kenneth Gordon and Silicon Valley’s Anthony McCusker, has also played a key role on investments into digital health, fintech, mobility tech and blockchain. Other lead partners include Bill Schnoor on the technology side and William Collins in life sciences. All partners based in Boston unless otherwise stated.
United States > Healthcare > Life sciences
Goodwin’s life sciences team assist a diverse roster of pharmaceutical companies – both public and private – and life science venture capital firms. Mitchell Bloom and Kingsley Taft jointly lead the team; Taft primarily advises life sciences companies throughout their life cycles on formation, venture financings, and IPOs, while Bloom is active in the biotechnology and medical IT spaces. Boston-based Robert Puopolo maintains a transactions focused practice, handling joint ventures and life sciences M&A. In San Francisco, Alexander Varond takes the lead on litigious matters concerning biosimilars and the Hatch-Waxman Act. Stuart Cable is particularly adept at advising on corporate governance and venture sourced investment, while Danielle Lauzon assists boards and management teams of therapeutics and bioscience companies. A large team including Philadelphia-based Rachael Bushey, who specializes in transactional and governance work in the pharma and biotech space, joined the firm from Troutman Pepper in January 2023. All named practitioners are based in Boston unless specified otherwise.
Lawyer Rankings
- Next Generation Partners United States > M&A/corporate and commercial > Venture capital and emerging companies
- Venture capital and emerging companies United States > M&A/corporate and commercial
- Life sciences United States > Healthcare
Top Tier Firm Rankings
- Finance > Financial services regulation
- Industry focus > Cannabis
- Intellectual property > Patents: licensing
- Real estate > Real estate investment trusts (REITs)
- Media, technology and telecoms > Technology transactions
- M&A/corporate and commercial > Venture capital and emerging companies
Firm Rankings
- Finance > Capital markets: equity offerings
- Industry focus > Education
- Labor and employment > ERISA litigation
- Finance > Fintech
- Healthcare > Life sciences
- Dispute resolution > M&A litigation: defense
- M&A/corporate and commercial > M&A: middle-market ($500m-999m)
- Investment fund formation and management > Mutual/registered/exchange-traded funds
- Dispute resolution > Securities litigation: defense
- Finance > Capital markets: debt offerings
- International Trade > CFIUS
- M&A/corporate and commercial > Corporate governance
- Media, technology and telecoms > Cyber law (including data privacy and data protection)
- Dispute resolution > E-discovery
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Dispute resolution > Financial services litigation
- Antitrust > Merger control
- Intellectual property > Patents: litigation (full coverage)
- Investment fund formation and management > Private equity funds (including venture capital)
- Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
- Real estate > Real estate
- M&A/corporate and commercial > Shareholder activism
- Intellectual property > Trade secrets (litigation and non-contentious matters)
- Tax > US taxes: non-contentious
- Labor and employment > Workplace and employment counseling
- Labor and employment > Employee benefits, executive compensation and retirement plans: design
- Dispute resolution > Leading trial lawyers
- M&A/corporate and commercial > Private equity buyouts: large deals ($500m+)
- Healthcare > Service providers
- International Trade > Customs, export controls and economic sanctions
- Dispute resolution > Leading trial lawyers
- Finance > Restructuring (including bankruptcy): corporate
- Dispute resolution > Appellate: courts of appeals / Appellate: supreme courts (states and federal)
- Finance > Commercial lending
- Dispute resolution > Corporate investigations and white-collar criminal defense
- Intellectual property > Patents: prosecution (including re-examination and post-grant proceedings)